Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cesca Therapeutics (KOOL)

Cesca Therapeutics (KOOL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,420
  • Shares Outstanding, K 2,416
  • Annual Sales, $ 9,670 K
  • Annual Income, $ -39,720 K
  • 60-Month Beta 1.07
  • Price/Sales 1.20
  • Price/Cash Flow N/A
  • Price/Book 1.87
Trade KOOL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.57
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 11/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +90.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.18 +22.97%
on 10/25/19
6.90 -25.50%
on 10/01/19
-1.49 (-22.47%)
since 09/30/19
3-Month
2.60 +97.69%
on 08/14/19
7.00 -26.57%
on 09/27/19
+2.22 (+76.03%)
since 07/30/19
52-Week
2.10 +144.76%
on 12/24/18
7.00 -26.57%
on 09/27/19
+2.34 (+83.57%)
since 10/30/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 5.45
1st Resistance Point 5.29
Last Price 5.14
1st Support Level 4.89
2nd Support Level 4.65
3rd Support Level N/A

See More

52-Week High 7.00
Last Price 5.14
Fibonacci 61.8% 5.13
Fibonacci 50% 4.55
Fibonacci 38.2% 3.97
52-Week Low 2.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar